Live Breaking News & Updates on Adrianus Van Herk

Stay updated with breaking news from Adrianus van herk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no ....

United States , Vlaams Gewest , Region Flamande , Adrianus Van Herk , Company Premarket Approval , Company Or Sequanamedical , Belgian Financial Services , Sequana Medical , Euronext Brussels , Participatiemaatschappij Vlaanderen , Het Vlaams Gewest , Belgian Act , Belgian Transparency Act , Markets Authority , Premarket Approval , North American , Data Safety Monitoring Board , The Company , Voting Rights , Euronext Brussels , Sequana Medical , Heart Failure , Articipatiemaatschappij Vlaanderen Nv , Adrianus Van Herk ,

Sequana Medical NV: Transparency Notifications from Shareholders

Sequana Medical NV: Transparency Notifications from Shareholders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Vlaams Gewest , Region Flamande , United States , Adrianus Van Herk , Dennis Riedl , Belgian Financial Services , Company Or Sequanamedical , Company Premarket Approval , Euronext Brussels , Participatiemaatschappij Vlaanderen , Het Vlaams Gewest , Belgian Act , Sequana Medical , Belgian Transparency Act , Markets Authority , Premarket Approval , North American , Data Safety Monitoring Board ,

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no ....

United States , Vlaams Gewest , Region Flamande , Adrianus Van Herk , Company Premarket Approval , Company Or Sequanamedical , Belgian Financial Services , Sequana Medical , Euronext Brussels , Participatiemaatschappij Vlaanderen , Het Vlaams Gewest , Belgian Act , Belgian Transparency Act , Markets Authority , Premarket Approval , North American , Data Safety Monitoring Board ,